Ran Zheng's most recent trade in Caribou Biosciences Inc was a trade of 40,500 Option to purchase Common Stock done . Disclosure was reported to the exchange on Feb. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caribou Biosciences Inc | Ran Zheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 40,500 | 40,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Ran Zheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 39,500 | 39,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Ran Zheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 21,500 | 21,500 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Ran Zheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2021 | 13,750 | 13,750 | - | - | Option to purchase Common Stock | |
| Caribou Biosciences Inc | Ran Zheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 44,000 | 44,000 | - | - | Stock Option (right to buy) |